A Chemically Remodeled Cellular Chaperone Targets Active State Mutant KRAS

Cancer Discov. 2023 Oct 5;13(10):2120. doi: 10.1158/2159-8290.CD-RW2023-134.

Abstract

Formation of the CYPA:compound:KRASG12C tricomplex inhibits oncogenic signaling and tumor progression.